Veradermics
veradermics.com
Actively hiring
Biologics & Biosimilars
Dermatology
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$268.8M
6 rounds on record
Latest round
$30M
Convertible Note · May 2026 · 4 mo ago
Backers
1
Longitude Capital
The money's age
Fresh money
4 months since the last round · not hiring
Momentum
20/100
fresh money
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Convertible Note | May 2026 | $30M | — | SEC Form D |
| Venture round | Oct 2025 | $135M | — | SEC Form D |
| Venture round | Nov 2024 | $66.6M | — | SEC Form D |
| Venture round | Apr 2023 | $15M | — | SEC Form D |
| Venture round | Sep 2021 | $22.2M | — | SEC Form D |
| Debt Financing | Sep 2020 | $476k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | VeraDermics, Inc | sec |
Founders and leadersfrom filings, registers and the company's site
Timothy DursoExecutive Officer, DirectorSEC Form D
Reid WaldmanExecutive Officer, DirectorSEC Form D
Michael GrecoExecutive OfficerSEC Form D
Mark NeumannExecutive OfficerSEC Form D
Dominic CarranoExecutive OfficerSEC Form D
Tim DursoExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Longitude Capital Similar startupsby what they do, their industry and backers
CAMPfield Therapeutics is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor…
Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics. The…
Neurogastrx, Inc.. Thank you for visiting the website for Neurogastrx, Inc. ("Company"), a privately held, late clinical-stage…
Nuance Pharma are an innovation focused biopharmaceutical company, with both late-stage clinical pipeline and commercial stage asset…
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory…
People
Timothy Durso
Executive Officer, Director
Reid Waldman
Executive Officer, Director
Michael Greco
Executive Officer
Mark Neumann
Executive Officer
Dominic Carrano
Executive Officer
Tim Durso
Executive Officer
Vladimir Coric
Director
Jane Grant-Kels
Director
John Childs
Director
Amanda Birdsey-Benson
Director
Christopher Eklund
Director
Patrick Enright
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
San Antonio
United States
HQ
New Haven
United States
Sales office
Dr. Waldman is the Chief Executive Officer (CEO) of Veradermics. Under his stewardship, he has positioned Veradermics fo
470 James St., Suite 2A, New Haven, CT 06513
Financials
Total raised
$269.3M
Latest round
Convertible Note
Funding rounds
6